chrisvoncsefalvay/vaers-outcomes huggingface dataset:
STROKE; This spontaneous report received from a patient via a company representative from social media concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number were not reported, and expiry: UNKNOWN) 1 total, dose number in series 1, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included acetylsalicylic acid. On an unspecified date, the patient experienced "stroke". It was reported that "I had the Johnson and Johnson vaccine and three weeks later I had a stroke up until then I wasn't even taking so much is an aspirin I'm not taking any boosters from anybody" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20211248907-Covid-19 vaccine ad26.CoV-2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Area of erythema over right deltoid (inject site) 17 cm by 14 cm induration and shoulder area. Warm to touch. Keflex given 960 with warm compasses. Follow up on 4/4/03 - improved.
Per patient report received Pfizer COVID vaccine on 8/9/21 with no issues.  Received 2nd dose on 8/30/21 and on 9/1/21 began experiencing left eye flashes of laight.  Saw eye doctor twice, who thought it was due to age.  Still experiencing the issue as of 11/19/21.  Also reports nothing tastes good, no energy, and unsteady gait at times.
Fever, chills, mild body aches, feeling tired. Started at 3am on 1/1/21, was resolved by morning of 1/2/21.
Beginning 12 hours post-vaccination: 100.4 fever, chills, pain at site of  injection, swollen underarm near site of injection,  hip, knee and ankle pain, nausea, headache. Symptoms subsided about 48 hours post vaccination.
Patient received the covid vaccine dose #2 on 01/13/2021.   c/o new onset of fever, HA, dizziness, bodyache, and L axillary swelling and tenderness  few hours after the injection.  Feel better today but very fatigue.  Denies any respiratory or GI symptoms.
2 days after received the vaccines, She expressed (high fever, 102, 103 F, then slightly lower the next week. She was unable to get out of bed without, feeling terribly nauseated. She was continued to her bed all week. She was urged to go to the ER but she did not, saw her PCP next day who affirmed adverse reaction.
Chills, headache, body ache, fever, coughing, disorientation, loss of appetite, dizziness, extreme fatigue
After the bivalent vaccine, I suffered an ischemic stoke 4 weeks later with no know history of stokes in the family. It was in my left cerebellum.
Lower extremity swelling bilaterally; This is a spontaneous report from a contactable Physician.   A 13-year-old male patient received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via intramuscular route of administration at arm right, on 10Aug2021 (age at vaccination: 13 years), as a dose 2, single for COVID-19 immunization. The patient's medical history includes asthma and ADHD. The patient concomitant medications include albuterol, beclometasone dipropionate (QVAR), cetirizine and fluticasone propionate (flonase). The patient previously received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via intramuscular route of administration at arm right, on an unspecified date in Jul2021, age at vaccination: 13 years), as a dose 1, single for COVID-19 immunization. On an unspecified date in Aug2021, the patient had lower extremity swelling bilaterally. Reportedly the patient D-Dimer test was normal. The patient visited Emergency room/department or urgent care as a result of adverse event. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. Outcome of the event was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
At end of observation time, patient experienced dry heaves,  she became cold transferred to stretcher,  chills   and rigors present no thermometer, hr 97 100% 152/108, a11:30  dry heaves seized.  MD   notified.  Patient BP 140/66 at 1135. present at 1135.  Patient resting,  1145  MD in spoke wit   patient.  1210 pt walked to bathroom experiencing some dizziness, voided.  bp 149/82 84 100%  Home with husband.  Patient states every one in her family vaccinated had robust side effects.
PT FELT NAUSEA, VOMITED HAD FEVER FOR COUPLE OF DAYS. OK NOW.
15-20 minutes post vax arm started burning, advised client to apply ice pack. Take Tylenol, Saturday client stated that symptoms subsided after about 1 hour.
Severe Chills and shaking repeated nightly for 5 nights Body aches, vertigo, nausea, headache , muscle cramp at injection site resolved slowly over 3 weeks
The location of her arm is felt warm and also red and swollen. Pt has been advised to take some ibuprofen in order to keep the swelling goes down.
Headache; Dizziness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEADACHE (Headache) and DIZZINESS (Dizziness) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced PYREXIA (Fever). On 01-Mar-2021, the patient experienced HEADACHE (Headache) and DIZZINESS (Dizziness). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) was resolving and HEADACHE (Headache) and DIZZINESS (Dizziness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Cramps leg, Weight gain, Tachycardia, pain on joints and muscles, Back Pain, Memory increase in forgetfulness
The Moderna vaccine was given outside of the normal 12 hour window after the first puncture, but within 24 hours. The manufacturer was contacted, the dose was verified as viable, but the patient should monitor for injection site reactions and signs of infection. No adverse reactions reported at this time.
weakness; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), HEADACHE (Headache) and PYREXIA (Fever) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ASTHENIA (weakness), HEADACHE (Headache) and PYREXIA (Fever). On 24-Jan-2021, ASTHENIA (weakness), HEADACHE (Headache) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-297468 (Patient Link).
On 4/21/15 patient was given varicella vaccine and Hep B vaccine. Patient had full body papular rash and a localized irritation at injection site of varicella.
Woke up day after 2nd Pfizer Covid vaccine dose  with feeling in arms and legs but unable to move. Worse in arms than legs initially but by end of day legs felt same as arms. Couldn?t get out of bed until early evening when my husband helped me to the bathroom and back to bed. Feeling lasted for 4 days but  did not worsen any further and gradually resolved. Remained in bed for 4 days. Did not seek additional medical care although speaking with some health care professionals my symptoms described were noted to be ?Gullain-Barre like?. Was advised recently that I should report this.
Classic shingles outbreak about 10 days after receiving shingles vaccine. Tx w/ acyclovir, pain med.
Received Hep-A at 17:00 and 4-6 hours afterwards, complained of thigh pain, developed temperature of 104.3F (ax), very irritable, talked about snakes and seemed to be picking critters off shirt. Admitted for observation due to increased temperature and irritability.
Patient received 2 vaccinations (Shingrix and Flublok) on October 6, 2021. She reported prominent numbness/tingling in her fingertips on both hands, mild numbness in her lips and cheeks, and numbness/weakness in her knees on October 8, 2021. She was counseled to watch the symptoms and report them to her prescriber if they did not improved or resolve in a few days.
Lymphadenopathy vs swollen parotid glands, fever, congestion, fussy, breathing heavy. To MD for evaluation on 6/5/06. Possible SE of MMR.
1st moderna lot number 027A21A given 3/14/21. Pt woke up with right side weakness and aphasia. Still ambulating on his own. At 0800 he went with his wife to get his second Covid-19 vaccination. Symptoms progressed until he was unable to speak or move his right side at all. Family called 911. Pt admitted to hospital with Dx of Left MCA Stroke.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Patient's pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/allergies were reported. On 15-JUN-2016, the patient was vaccinated with improperly stored doses of GARDASIL 9 (lot # L043213, expiration 28-AUG-2017) (strength, dosing details and anatomical location were not reported). No adverse effects were reported. No product quality complaint was involved. This is one of the several reports received by the same reporter. Additional information has been requested.
Sore arm at injection site on left arm. Tingling and numbest to left fingers. Then, up to left shoulder. Went to urgent care as require by hosptial on 11/7/2012 to be elevated of condition.
This case was reported by a nurse via another manufacturer and described the occurrence of headache in an adult female subject of unspecified age who was vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis. The reporting nurse was also the subject. On an unspecified date on or prior to 13 October 2003, the subject received an unspecified dose of Engerix-B. At an unspecified time after vaccination with Engerix-B, the subject experienced headache, neck stiffness, and joint pain. As a result of the events, the subject sought medical attention. At the time of reporting, the subject was still experiencing symptoms. No further information was reported. The outcome was reported to be recovering with sequalae.
I experienced a severe canker sore (herpes virus) breakout in my mouth. I normally will get one or two once every now and then (every few months or so). About 48 hours after the second dose, I woke up; I experienced a severe canker sore (herpes virus) breakout in my mouth. I normally will get one or two once every now and then (every few months or so). About 48 hours after the second dose, I woke up; it was very painful; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 27-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported, expiry date: unknown) via an unspecified route of administration, administered in Left arm on 25Aug2021 as dose 2, single for COVID-19 immunisation (age at Vaccination: 27-years-old) from Doctor's office/urgent care. Medical history included gastritis and jejunitis. Concomitant medications included sertraline hydrochloride (ZOLOFT); desvenlafaxine succinate monohydrate (PRISTIQ); lamotrigine (LAMICTAL). All of them were taken for an unspecified indication, start and stop date were not reported. The patient previously took azithromycin [azithromycin dihydrate] and experienced Allergy. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported, expiry date: unknown) on 04Aug2021 intramuscularly in Left Arm as dose 1, single, for COVID-19 immunization at Doctor's office/urgent care. The patient was not tested for covid-19 before or after vaccination, and had not received other vaccines within 4 weeks prior to the vaccination. The patient had received Zoloft, Pristiq and, Lamictal. two weeks prior to the vaccination. On 27Aug2021 the patient reported "experienced a severe canker sore (herpes virus) breakout in my mouth. I normally will get one or two once every now and then (every few months or so). About 48 hours after the second dose, I woke up with 7 in mouth. 2 on my tongue, 3 inside on my bottom lip, and 2 inside of my top lip. Over the next few days, 3 more appeared. They healed on their own but it was very painful and I could hardly eat for about 3 days. The patient had not received treatment for the events. The outcome of the events was recovering.  Lot/Batch number was not provided and will request during follow-up.
Td given & w/in one min pt lost consciousness, had pallor became nauseous; eyes remained open w/pupils dilated arms drew up w/tonic-clonic movements;
One day following administration of an anthrax vaccine into left deltoid, the patient developed a papular rash first affecting the left arm, then migrating to the right arm and then torso (11/7/2021).  Rash was pruritic and scattered diffusely on the arms and torso primarily.  Treatment was started on 11/23/21 with triamcinolone cream and a prednisone taper.  Symptoms were improving, but not resolved at the time of this VAERS submission.  The patient reports no other symptoms following vaccination.
Right after dose I became nauseated and had to sit with a nurse for a half hour. An hour later I had to go to the ER because I was having shortness of breathe, it felt like something was on my lungs. I developed Hives which lasted for 5 days.
Patient is not feeling well after receiving first dose Covid-19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Patient is not feeling well after receiving first dose Covid-19 Vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Patient is not feeling well after receiving first dose Covid-19 Vaccine). At the time of the report, MALAISE (Patient is not feeling well after receiving first dose Covid-19 Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Caller is a nurse reporting a temperature excursion, requesting stability data; This spontaneous report as received from a registered nurse referring to a patient of unknown age and gender. The pertinent medical history, concomitant therapies and drug allergy or reactions were unknown.  On 20-OCT-2020, the patient was vaccinated with 1 dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number S038700, which has been verified to be valid, expiration date reported and validated as 01-DEC-2021) for prophylaxis (formulation, strength, vaccination scheme, route of administration and anatomical site of vaccination were not reported). The vaccine administered experienced a temperature excursion of -6.6 degrees Celsius for a time frame of 1 hour and 45 minutes, as recorded by a data logger. There was no previous temperature excursion reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2010USA010348: US-009507513-2010USA010299: US-009507513-2010USA010735: US-009507513-2010USA010384: US-009507513-2010USA010598: US-009507513-2010USA010518: US-009507513-2010USA010577: US-009507513-2010USA010526: US-009507513-2010USA010709:
Left arm (injection site) has rash, hot to touch, slightly itchy  The rash is south of actual injection site (I have a bruise where the needle went)
Delayed reaction that is sometimes called COVID arm. Last night I woke up with an itchy painful red lump at the injection site. I never had anything other than pain at the of the injection until last night. In fact the arm pain had completely dissipated a few days prior
Myocarditis: Chest pain and small frequent convulsions in my center chest. Heart beats that feel irregular. Leaning forward and sleeping on my stomach make it happen, and make it happen more frequently. Heart beats that feel irregular.
The morning after receiving the second dose of the vaccine I had body aches and joint pain, it progressively got worse throughout the day. The night after receiving the second dose of the vaccine I had severe stomach pain and vomited a large amount. For about a week following the second dose of the vaccine I continued to have severe back and joint pain as well as pain in my upper back and chest with breathing.
Information has been received from a physician concerning a 17 year old female who on 07-MAY-2007 was vaccinated with a 0.5 ml dose of Gardasil. On approximately 21-MAY-2007, two weeks after getting the vaccination, the patient developed a "besicular" rash. The patient was seen by her physician again on 14-JUN-2007 and the rash had continued to spread. The course of treatment for the rash included PREDNISONE and ZYRTEC. The "besicular" rash persisted. Additional information has been requested. This is in follow-up to report(s) previously submitted on 7/16/2007.  Initial and follow-up information has been received from a physician concerning a 17 year old female with a history of psoriasis who on 07/MAY/2007 was vaccinated with the first 0.5 ml dose of GARDASIL.  On approximately 21-MAY-2007, two weeks after getting the vaccination, the patient developed a rash on her thighs, arms, abdomen and back which was macular in nature and itchy.  The patient was seen by her physician on 14-JUN-2007.  The course of treatment for the rash included PREDNISONE and ZYRTEC.  The rash lasted for more than three weeks after the patient was vaccinated with the first dose of GARDASIL.  At the time of the report, the patient had recovered.  There were no laboratory or diagnostic tests performed.  Additional information is not expected.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (COVID-19 VACCINE MODERNA), in Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "CIDP" (unspecified if ongoing); "DM2" (unspecified if ongoing); "Known allergies: Kiwi" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a medical assistant refers to a 14 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 08-JUL-2014 the patient was vaccinated with first dose of GARDASIL (dose, frequency and route of administration were not reported) (lot # K005083, expiry date: 04-NOV-2016) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for GARDASIL. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927,  1407USA012928, 1407USA012929, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012986, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013, and 1407USA013014 (same reporter link). Additional information has been requested.
High blood pressure, heart fluttering and palpitations, migraine, visual disturbance,  insomnia  All of these lasted 6 weeks
24-28 hours after vaccination, patient developed urticarial reaction diffusely over body. Hives all blanch, none larger than 1 cm in size. No respiratory or GI involvement, no mucosal involvement. Also with a large red area over left upper arm consistent with an arthus reaction.
Patient awoke with facial droop on same side as the vaccine was given.  Of interest, she had the forehead sparing and so a stroke was strongly considered.  A stroke was ruled out and she was diagnosed with Bell's like palsy
This spontaneous report as received from a registered nurse refers to a 6 month old patient. The patient's concurrent conditions, medical history and drug allergies were not reported. On 14-DEC-2016, the patient was vaccinated with improperly stored ROTATEQ, oral, (dose not reported) from lot # M007311 (expiry date: unspecified) for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all correspondence has been received. Follow-up information indicated that suspect product with the lot# M007311 had not actually involved in the previously reported temperature excursion. Therefore, case # 1612USA012736 is being deleted from our files on generic rotavirus vaccine, live, oral, pentavalent. This is an amended report, as corrected. The reference type for the number US-009507513-1610USA014706 has been changed from Company Number to Linked Report.; Sender's Comments: US-009507513-1610USA008140: US-009507513-1610USA014705: US-009507513-1610USA014706.